Down‐staging of hepatocellular carcinoma via external‐beam radiotherapy with subsequent liver transplantation: A case report
Alan Wigg, Kenneth Hon, Leigh Mosel, Nicole Sladden, Kevin Palumbo – 25 July 2013 – Despite the widespread use of locoregional therapies [radiofrequency ablation and transarterial chemoembolization (TACE)], there is currently a lack of high‐quality evidence supporting their use for hepatocellular carcinoma (HCC) in patients on the liver transplantation (LT) waiting list or requiring down‐staging. Radiotherapy has rarely been used in this setting and has usually been in the form of more complex and less accessible techniques such as proton‐beam and stereotactic body radiation therapy.